Neurology and Neurosurgery - Global Neurology Academy

225-240 of 455

Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NeuroFrontiers
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiers
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiers
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
- Thomas Karikari, PhD
Preventing Alzheimer’s Disease Through Lifestyle Interventions
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiers
Preventing Alzheimer’s Disease Through Lifestyle Interventions
- Michele Longo, MD
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiers
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
- Michele Longo, MD
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiers
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
- Robert Walker, PharmD
- Deanna L. Kelly, PharmD, BCPP
Advancing Schizophrenia Care: Challenges and Promising New Therapies
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiers
Advancing Schizophrenia Care: Challenges and Promising New Therapies
- Charles Turck, PharmD, BCPS, BCCCP
- Andrew J. Cutler, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiers
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
- Clifford Jack Jr., MD
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
- Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
- Ashley Baker, MSN, PMHNP
- Suzanne E. Schindler, MD, PhD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
- Ashley Baker, MSN, PMHNP
- Vishnu Pandurangadu, MD/MBA, FACEP
- Pritikanta Paul, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiers
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiers
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
NeuroFrontiers
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
- John A. Morren, MD, FAAN, FAANEM
Bridging the Gap to Improved Schizophrenia Treatment Options
Bridging the Gap to Improved Schizophrenia Treatment Options
NeuroFrontiers
Bridging the Gap to Improved Schizophrenia Treatment Options
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
NeuroFrontiers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers

15/11